| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MSACW | Exit | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $0 | – | -29,776 | -100.0% | -0.00% | – |
| EUCRW | Exit | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $0 | – | -78,059 | -100.0% | -0.00% | – |
| Exit | EQRX INC*w exp 12/17/202 | $0 | – | -35,239 | -100.0% | -0.01% | – | |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -150,000 | -100.0% | -0.68% | – |
| SILK | Exit | SILK RD MED INC | $0 | – | -15,000 | -100.0% | -0.73% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -3,500 | -100.0% | -0.81% | – |
| RAIN | Exit | RAIN ONCOLOGY INC | $0 | – | -120,000 | -100.0% | -0.88% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.90% | – |
| PEN | Exit | PENUMBRA INC | $0 | – | -5,000 | -100.0% | -1.02% | – |
| GERN | Exit | GERON CORP | $0 | – | -500,000 | -100.0% | -1.11% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -30,000 | -100.0% | -1.20% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -5,750 | -100.0% | -1.40% | – |
| KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -60,000 | -100.0% | -1.44% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -70,000 | -100.0% | -1.63% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -20,000 | -100.0% | -2.19% | – |
| CNMD | Exit | CONMED CORP | $0 | – | -27,500 | -100.0% | -2.23% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -110,000 | -100.0% | -2.63% | – |
| Exit | HYPERFINE INC | $0 | – | -3,880,900 | -100.0% | -2.99% | – | |
| Exit | ACRIVON THERAPEUTICS INC | $0 | – | -284,201 | -100.0% | -3.00% | – | |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -164,440 | -100.0% | -6.90% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -321,380 | -100.0% | -33.35% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -367,765 | -100.0% | -34.88% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.